Achieving highly specific cell targeting with lipid nanoparticles (LNPs) often means complex development cycles and significant R&D investment.
What if you could “clip on” targeting capabilities to the LNPs you already have in your lab?
Tiva Biosciences is proud to introduce our Ready-to-Target binder-lipid product line. These innovative products use lipid-conjugated, high-affinity binders that integrate seamlessly into LNPs with a simple mixing step. This empowers researchers to quickly create targeted LNPs for testing in specific cell types.
Key characteristics:
• Simple mix and use process
• >80% LNPs integrated with binders
• >60% transfection in targeted cells
Our initial library includes CD8 and CD3 binder-lipid-conjugates, and we are rapidly expanding our offerings.